Current Diabetes ReportsPub Date : 2023-06-01Epub Date: 2023-04-13DOI: 10.1007/s11892-023-01503-5
Eileen R Faulds, Kathleen M Dungan, Molly McNett
{"title":"Implementation of Continuous Glucose Monitoring in Critical Care: A Scoping Review.","authors":"Eileen R Faulds, Kathleen M Dungan, Molly McNett","doi":"10.1007/s11892-023-01503-5","DOIUrl":"10.1007/s11892-023-01503-5","url":null,"abstract":"<p><strong>Purpose of review: </strong>The aim of this review is to identify the implementation approaches, strategies, and outcomes for continuous glucose monitoring (CGM) in the intensive care unit (ICU). Medline and Web of Science databases were searched to report relevant literature published between September 12, 2016 and September 12, 2021. Implementation outcomes and strategies, defined by the Expert Recommendations for Implementing Change (ERIC) project, were extracted.</p><p><strong>Recent findings: </strong>Of the 324 titles reviewed, 16 articles were included in the review. While no studies were identified as implementation research, 14 of 16 identified implementation strategies that aligned with ERIC definitions. Included studies described a multi-disciplinary approach. Clinical outcomes included Mean Absolute Relative Difference (MARD), ranging from 7.5 to 15.3%, and 33-71% reduction in frequency of point-of-care (POC) blood glucose monitoring (BGM) using hybrid protocols. This scoping review provides valuable insight into the process of CGM implementation in the ICU. Continued research should include implementation outcomes to inform widespread utilization.</p>","PeriodicalId":10898,"journal":{"name":"Current Diabetes Reports","volume":"23 6","pages":"69-87"},"PeriodicalIF":5.2,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10098233/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9433941","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Paula Andrea Taborda Restrepo, Jorge Acosta-Reyes, Andrés Estupiñan-Bohorquez, María Alejandra Barrios-Mercado, Nestor Fabián Correa Gonzalez, Alejandra Taborda Restrepo, Noël C Barengo, Rafael Gabriel
{"title":"Comparative Analysis of Clinical Practice Guidelines for the Pharmacological Treatment of Type 2 Diabetes Mellitus in Latin America.","authors":"Paula Andrea Taborda Restrepo, Jorge Acosta-Reyes, Andrés Estupiñan-Bohorquez, María Alejandra Barrios-Mercado, Nestor Fabián Correa Gonzalez, Alejandra Taborda Restrepo, Noël C Barengo, Rafael Gabriel","doi":"10.1007/s11892-023-01504-4","DOIUrl":"https://doi.org/10.1007/s11892-023-01504-4","url":null,"abstract":"<p><strong>Purpose of review: </strong>Type 2 diabetes mellitus (T2DM) is one of the leading causes of death and disability in the world. The majority of diabetes deaths (> 80%) occur in low- and middle-income countries, which are predominant in Latin America. Therefore, the purpose of this article is to compare the clinical practice guideline (CPG) for the pharmacological management of T2DM in Latin America (LA) with international reference guidelines.</p><p><strong>Recent findings: </strong>Several LA countries have recently developed CPGs. However, the quality of these guidelines is unknown according to the AGREE II tool and taking as reference three CPGs of international impact: American Diabetes Association (ADA), European Diabetes Association (EASD), and Latin American Diabetes Association (ALAD). Ten CPGs were selected for analysis. The ADA scored > 80% on the AGREE II domains and was selected as the main comparator. Eighty percent of LA CPGs were developed before 2018. Only one was not recommended (all domains < 60%). The CPGs in LA have good quality but are outdated. They have significant gaps compared to the reference. There is a need for improvement, as proposing updates every three years to maintain the best available clinical evidence in all guidelines.</p>","PeriodicalId":10898,"journal":{"name":"Current Diabetes Reports","volume":"23 6","pages":"89-101"},"PeriodicalIF":4.2,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10160131/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9421954","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Youth-Onset Type 2 Diabetes: Burden of Complications and Socioeconomic Cost.","authors":"Isabella Marranzini Rodriquez, Katie L O'Sullivan","doi":"10.1007/s11892-023-01501-7","DOIUrl":"https://doi.org/10.1007/s11892-023-01501-7","url":null,"abstract":"<p><strong>Purpose of review: </strong>With the rise in prevalence of youth-onset type 2 diabetes (T2DM), it is imperative to understand the clinical burden of the disease and the socioeconomic burden this disease imposes. We review the most recent data on youth-onset T2DM, including its pathophysiology, complications, and treatment. We also review existing data to determine the socioeconomic burden of youth-onset T2DM.</p><p><strong>Recent findings: </strong>The incidence of youth-onset T2DM is rising, and significantly accelerated following the COVID-19 pandemic. Youth with T2DM are more frequently from families of racial/ethnic minorities and lower socioeconomic status. Youth-onset T2DM has more rapid disease progression compared to adult-onset type 2 diabetes. It results in earlier and more severe microvascular and macrovascular complications compared to both adult-onset T2DM and youth-onset type 1 diabetes (T1DM). While there is a lack of data describing the socioeconomic cost of youth-onset T2DM, based on extrapolation from analyses of the burden of T2DM in adults and T1DM in youth, we propose that youth-onset T2DM has higher direct and indirect costs than adult-onset T2DM. Youth-onset T2DM presents a significant clinical and socioeconomic burden due to its aggressive presentation and earlier appearance of complications. Additional research is needed regarding the cost of illness in this population.</p>","PeriodicalId":10898,"journal":{"name":"Current Diabetes Reports","volume":"23 5","pages":"59-67"},"PeriodicalIF":4.2,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037371/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9483090","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jenine Y Stone, Lindsay S Mayberry, Kate Clouse, Shelagh Mulvaney
{"title":"The Role of Habit Formation and Automaticity in Diabetes Self-Management: Current Evidence and Future Applications.","authors":"Jenine Y Stone, Lindsay S Mayberry, Kate Clouse, Shelagh Mulvaney","doi":"10.1007/s11892-023-01499-y","DOIUrl":"https://doi.org/10.1007/s11892-023-01499-y","url":null,"abstract":"<p><strong>Purpose of review: </strong>Diabetes is a chronic condition that requires consistent self-management for optimal health outcomes. People with diabetes are prone to burnout, cognitive burden, and sub-optimal performance of self-management tasks. Interventions that focus on habit formation have the potential to increase engagement by facilitating automaticity of self-management task performance. The purpose of this review is to (1) clarify the conceptualizations of habit formation and behavioral automaticity in the context of health behavior interventions, (2) review the evidence of habit in relation to behaviors relevant to diabetes self-management, and (3) discuss opportunities for incorporating habit formation and automaticity into diabetes self-management interventions.</p><p><strong>Recent findings: </strong>Modern habit research describes a habit as a behavior that results over time from an automatic mental process. Automatic behaviors are experienced as cue-dependent, goal-independent, unconscious, and efficient. Habit formation requires context-dependent repetition to form cue-behavior associations. Results of diabetes habit studies are mixed. Observational studies have shown positive associations between habit strength and target self-management behaviors such as taking medication and monitoring blood glucose, as well as glycemic outcomes such as HbA1c. However, intervention studies conducted in similar populations have not demonstrated a significant benefit of habit-forming interventions compared to controls, possibly due to varying techniques used to promote habit formation. Automaticity of self-management behaviors has the potential to minimize the burden associated with performance of self-management tasks and ultimately improve outcomes for people with diabetes. Future studies should focus on refining interventions focused on context-dependent repetition to promote habit formation and better measurement of habit automaticity in diabetes self-management.</p>","PeriodicalId":10898,"journal":{"name":"Current Diabetes Reports","volume":"23 4","pages":"43-58"},"PeriodicalIF":4.2,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9426766","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Sabrena F Noria, Rita D Shelby, Katelyn D Atkins, Ninh T Nguyen, Kishore M Gadde
{"title":"Weight Regain After Bariatric Surgery: Scope of the Problem, Causes, Prevention, and Treatment.","authors":"Sabrena F Noria, Rita D Shelby, Katelyn D Atkins, Ninh T Nguyen, Kishore M Gadde","doi":"10.1007/s11892-023-01498-z","DOIUrl":"https://doi.org/10.1007/s11892-023-01498-z","url":null,"abstract":"<p><strong>Purpose of review: </strong>Although bariatric surgery is the most effective treatment of severe obesity, a proportion of patients experience clinically significant weight regain (WR) with further out from surgery. The purpose of this review is to summarize the prevalence, predictors, and causes of weight regain.</p><p><strong>Recent findings: </strong>Estimating the prevalence of WR is limited by a lack of consensus on its definition. While anatomic failures such as dilated gastric fundus after sleeve gastrectomy and gastro-gastric fistula after Roux-en-Y gastric bypass can lead to WR, the most common causes appear to be dysregulated/maladaptive eating behaviors, lifestyle factors, and physiological compensatory mechanisms. To date, dietary, supportive, behavioral, and exercise interventions have not demonstrated a clinically meaningful impact on WR, and there is limited evidence for pharmacotherapy. Future studies should be aimed at better defining WR to begin to understand the etiologies. Additionally, there is a need for non-surgical interventions with demonstrated efficacy in rigorous randomized controlled trials for the prevention and reversal of WR after bariatric surgery.</p>","PeriodicalId":10898,"journal":{"name":"Current Diabetes Reports","volume":"23 3","pages":"31-42"},"PeriodicalIF":4.2,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906605/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9985088","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Sarah Corathers, Desireé N Williford, Jessica Kichler, Laura Smith, Emma Ospelt, Saketh Rompicherla, Alissa Roberts, Priya Prahalad, Marina Basina, Cynthia Muñoz, Osagie Ebekozien
{"title":"Implementation of Psychosocial Screening into Diabetes Clinics: Experience from the Type 1 Diabetes Exchange Quality Improvement Network.","authors":"Sarah Corathers, Desireé N Williford, Jessica Kichler, Laura Smith, Emma Ospelt, Saketh Rompicherla, Alissa Roberts, Priya Prahalad, Marina Basina, Cynthia Muñoz, Osagie Ebekozien","doi":"10.1007/s11892-022-01497-6","DOIUrl":"https://doi.org/10.1007/s11892-022-01497-6","url":null,"abstract":"<p><strong>Purpose of review: </strong>Although advances in diabetes technology and pharmacology have significantly and positively impacted diabetes management and health outcomes for some, diabetes care remains burdensome and can be challenging to balance with other life priorities. The purpose of this article is to review the rationale for assessment of psychosocial domains in diabetes care settings and strategies for the implementation of psychosocial screening into routine practice. Survey data from the Type 1 Diabetes Exchange Quality Improvement Network is highlighted.</p><p><strong>Recent findings: </strong>Implementation of psychosocial screening requires identifying the population; selecting validated tools to assess target domains; determining frequency of screening and mode of survey delivery; and scoring, interpreting, documenting, and facilitating referrals such that these processes are part of clinical workflows. Recognizing the influence of psychosocial factors for people with diabetes (PWD), professional society guidelines for comprehensive diabetes care recommend the integration of psychosocial screening into routine care.</p>","PeriodicalId":10898,"journal":{"name":"Current Diabetes Reports","volume":"23 2","pages":"19-28"},"PeriodicalIF":4.2,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763798/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9141673","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Current Diabetes ReportsPub Date : 2023-01-01Epub Date: 2023-01-14DOI: 10.1007/s11892-022-01496-7
Rachna Sannegowda, Karina Villalba, Ryan Suk, Shilpa Gurnurkar, Rachel M Wasserman
{"title":"Recent Rates of Substance Use Among Adolescents and Young Adults with Type 1 Diabetes in the USA.","authors":"Rachna Sannegowda, Karina Villalba, Ryan Suk, Shilpa Gurnurkar, Rachel M Wasserman","doi":"10.1007/s11892-022-01496-7","DOIUrl":"10.1007/s11892-022-01496-7","url":null,"abstract":"<p><strong>Purpose of review: </strong>Substance use is a major public health problem in adolescents and young adults (AYA) and is particularly dangerous for AYA with type 1 diabetes (T1D) due to additional health consequences related to T1D. Rates of substance use among AYA with T1D are difficult to ascertain. Currently, we aim to provide a summary of published rates of substance use, over the last 10 years, among AYA with T1D in the USA.</p><p><strong>Recent findings: </strong>This review included a database search, abstract screening, and synthesizing of articles published in the last 10 years that reported rates of substance use among AYA with T1D. We also compared rates to national survey data from the Center for Disease Control and Substance Abuse and Mental Health Services Administration. Of 138 articles, 123 abstracts were excluded due to non-relevance or because they were conducted outside of the USA; 15 articles were evaluated, and 8 provided original data on AYA with T1D. These 8 studies were summarized and compared to nationwide survey data. Most of the published rates of substance use among AYA with T1D were similar to national survey data for alcohol, tobacco, and marijuana. Rates of illicit drug use were lower among AYA with T1D. Despite additional health consequences, alcohol, tobacco, and marijuana use is about as prevalent among AYA with T1D as in the general US population. These findings emphasize the importance of conducting more research in this area, developing effective interventions, and incorporating prevention into standard clinical practices.</p>","PeriodicalId":10898,"journal":{"name":"Current Diabetes Reports","volume":"23 1","pages":"1-17"},"PeriodicalIF":4.2,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9839951/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10573944","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"SHORT Syndrome: an Update on Pathogenesis and Clinical Spectrum.","authors":"Naama Fisch Shvalb","doi":"10.1007/s11892-022-01495-8","DOIUrl":"https://doi.org/10.1007/s11892-022-01495-8","url":null,"abstract":"<p><strong>Purpose of review: </strong>This review describes the unique pathogenesis of SHORT syndrome, a rare genetic form of insulin resistance syndrome, and recent advances in understanding the underlying mechanisms. SHORT syndrome results from dysfunction of PI3K, but the mechanisms behind the clinical manifestations are not entirely understood. Elucidating these mechanisms may contribute to the understanding of the roles of insulin signaling and PI3K signaling in humans. There are paucity of data on treatment and outcomes.</p><p><strong>Recent findings: </strong>The clinical spectrum of the disorder appears wider than previously understood, and overlaps with other clinical syndromes. PI3K malfunction is associated with insulin resistance, decreased lipogenesis, increased energy expenditure, and possible IGF1 resistance. SHORT syndrome may be underdiagnosed, and should be considered in individuals with growth failure, craniofacial dysmorphism, and lipodystrophy. Much is still unknown about the optimal management and long-term outcomes.</p>","PeriodicalId":10898,"journal":{"name":"Current Diabetes Reports","volume":"22 12","pages":"571-577"},"PeriodicalIF":4.2,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10572058","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Psychosocial Assessment Tools for Youth with Type 1 Diabetes: a 10-Year Review.","authors":"Trevor Bell, Elizabeth Hazel","doi":"10.1007/s11892-022-01494-9","DOIUrl":"https://doi.org/10.1007/s11892-022-01494-9","url":null,"abstract":"<p><strong>Purpose of review: </strong>There is a notable lack of consistency in the measurement of psychosocial factors affecting youth with type 1 diabetes, resulting in a need for increased measurement standardization and establishment of measures tailored to capture unique experiences faced by youth. This review sought to assess 10 years of extant literature (2011 to 2020) to identify which established measurement tools are commonly used and to evaluate new measurement tools that were introduced during this period.</p><p><strong>Recent findings: </strong>There are a variety of psychosocial factors affecting youth, and assessment of these measures has shown substantial variability. Our review found that most frequently cited scales were those pertaining to self-efficacy, diabetes distress, family conflict, autonomy, and fear of hypoglycemia. During our review period, experts developed and validated 21 new scales, the majority of which sought to evaluate areas pertaining to diabetes distress. Of the common scales and newly developed scales identified in this review, psychometric properties showcase high reliability and validity, and items are becoming increasingly specific to youth but still lack assessment of how youth perceive technology's impact on diabetes management. The field would benefit from measures employing more nuanced age specificity and addressing technology usage.</p>","PeriodicalId":10898,"journal":{"name":"Current Diabetes Reports","volume":"22 12","pages":"549-569"},"PeriodicalIF":4.2,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10522790","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}